0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Original Research |

Alternate-Day Steroid Therapy in Lupus Nephritis

GEORGE L. ACKERMAN, M.D., F.A.C.P.
[+] Article and Author Information

Supported in part by grant FR49, Division of Research Facilities, National Institutes of Health, Bethesda, Md.

▸Requests for reprints should be addressed to George L. Ackerman, M.D., Department of Medicine, University of Arkansas Medical Center, 4301 W. Markham, Little Rock, Ark. 72201


Little Rock, Arkansas


Ann Intern Med. 1970;72(4):511-519. doi:10.7326/0003-4819-72-4-511
Text Size: A A A

Six patients with lupus nephritis were treated with a program of alternate-day steroid therapy using doses of 100 or 120 mg of prednisone every other day. Five of the patients had lupus glomerulonephritis; one had lupus glomerulitis. After 6 to 8 months of treatment there was histologic evidence of improvement of the renal lesion in all of the patients. During this time renal function improved in five patients. In one patient with severe lupus glomerulonephritis, creatinine clearance decreased by 30% early in treatment and then become stable. Improvement and stabilization of renal function were maintained after the steroid dosage was subsequently reduced. Beta1C globulin levels were normal after treatment in all of the patients. High-dose steroid therapy given in this way was tolerated very well. The patients remained free of Cushingoid changes and displayed a striking appearance of good health and well-being.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)